CD34(+)/CD38(−) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

BACKGROUND: CD33 is a well-known stem cell target in acute myeloid leukemia. So far, however, little is known about expression of CD33 on leukemic stem cells in chronic leukemias. DESIGN AND METHODS: We analyzed expression of CD33 in leukemic progenitors in chronic myeloid leukemia by multi-color fl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Herrmann, Harald, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Blatt, Katharina, Herndlhofer, Susanne, Rabitsch, Werner, Jäger, Eva, Mitterbauer-Hohendanner, Gerlinde, Streubel, Berthold, Selzer, Edgar, Schwarzinger, Ilse, Sperr, Wolfgang R., Valent, Peter
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ferrata Storti Foundation 2012
Ämnen:
Original Articles and Brief Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3269481/
https://ncbi.nlm.nih.gov/pubmed/21993666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.035006
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk